Biologic Markers of Antibiotic-Refractory Lyme Arthritis in Human: A Systematic Review

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2193-6382

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Biologic Markers of Antibiotic-Refractory Lyme Arthritis in Human: A Systematic Review ; day:30 ; month:11 ; year:2018 ; pages:1-18
Infectious diseases and therapy ; (30.11.2018), 1-18

Creator: Badawi, Alaa
Arora, Paul
Brenner, Darren

Contributor: SpringerLink (Online service)

DOI: 10.1007/s40121-018-0223-0

URN: urn:nbn:de:101:1-2019011723391668915082

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:03 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Badawi, Alaa
Arora, Paul
Brenner, Darren
SpringerLink (Online service)

Other Objects (12)

Lyme arthritis in Southern Norway - an endemic area for Lyme Borreliosis

Lyme-Arthritis : Von der Borrelien-Infektion zur postinfektiösen Arthritis

$Biologic predictors of clinical improvement in rituximab-treated refractory myositis$

Biologic predictors of clinical improvement in rituximab-treated refractory myositis

Administration costs of intravenous biologic drugs for rheumatoid arthritis

Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study

Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis

Was führt zur Antibiotika-refraktären Lyme-Arthritis bei Kindern?

$Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy$

Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy

$Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America$

Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America

Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?

Persistent Lyme Empiric Antibiotic Study Europe (PLEASE) - design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis

Hochschulschrift

Klinische und serologische Verlaufskontrollen bei 149 Patienten mit Lyme-Borreliose (Lyme-Arthritis, Erythema migrans, Acrodermatitis chronica atrophicans)

Lyme arthritis in Southern Norway - an endemic area for Lyme Borreliosis

Lyme-Arthritis : Von der Borrelien-Infektion zur postinfektiösen Arthritis

$Biologic predictors of clinical improvement in rituximab-treated refractory myositis$

Biologic predictors of clinical improvement in rituximab-treated refractory myositis

Administration costs of intravenous biologic drugs for rheumatoid arthritis

Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study

Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis

Was führt zur Antibiotika-refraktären Lyme-Arthritis bei Kindern?

$Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy$

Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy

$Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America$

Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America

Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?

Persistent Lyme Empiric Antibiotic Study Europe (PLEASE) - design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis

Hochschulschrift

Klinische und serologische Verlaufskontrollen bei 149 Patienten mit Lyme-Borreliose (Lyme-Arthritis, Erythema migrans, Acrodermatitis chronica atrophicans)

Lyme arthritis in Southern Norway - an endemic area for Lyme Borreliosis

Lyme-Arthritis : Von der Borrelien-Infektion zur postinfektiösen Arthritis

$Biologic predictors of clinical improvement in rituximab-treated refractory myositis$

Biologic predictors of clinical improvement in rituximab-treated refractory myositis

Administration costs of intravenous biologic drugs for rheumatoid arthritis

Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study

Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis

Was führt zur Antibiotika-refraktären Lyme-Arthritis bei Kindern?

$Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy$

Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy

$Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America$

Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America

Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?

Persistent Lyme Empiric Antibiotic Study Europe (PLEASE) - design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis

Hochschulschrift

Klinische und serologische Verlaufskontrollen bei 149 Patienten mit Lyme-Borreliose (Lyme-Arthritis, Erythema migrans, Acrodermatitis chronica atrophicans)

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Biologic Markers of Antibiotic-Refractory Lyme Arthritis in Human: A Systematic Review

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Lyme arthritis in Southern Norway - an endemic area for Lyme Borreliosis

Lyme-Arthritis : Von der Borrelien-Infektion zur postinfektiösen Arthritis

Biologic predictors of clinical improvement in rituximab-treated refractory myositis

Administration costs of intravenous biologic drugs for rheumatoid arthritis

Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study

Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis

Was führt zur Antibiotika-refraktären Lyme-Arthritis bei Kindern?

Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy

Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America

Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?

Persistent Lyme Empiric Antibiotic Study Europe (PLEASE) - design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis

Klinische und serologische Verlaufskontrollen bei 149 Patienten mit Lyme-Borreliose (Lyme-Arthritis, Erythema migrans, Acrodermatitis chronica atrophicans)

Lyme arthritis in Southern Norway - an endemic area for Lyme Borreliosis

Lyme-Arthritis : Von der Borrelien-Infektion zur postinfektiösen Arthritis

Biologic predictors of clinical improvement in rituximab-treated refractory myositis

Administration costs of intravenous biologic drugs for rheumatoid arthritis

Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study

Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis

Was führt zur Antibiotika-refraktären Lyme-Arthritis bei Kindern?

Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy

Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America

Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?

Persistent Lyme Empiric Antibiotic Study Europe (PLEASE) - design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis

Klinische und serologische Verlaufskontrollen bei 149 Patienten mit Lyme-Borreliose (Lyme-Arthritis, Erythema migrans, Acrodermatitis chronica atrophicans)

Lyme arthritis in Southern Norway - an endemic area for Lyme Borreliosis

Lyme-Arthritis : Von der Borrelien-Infektion zur postinfektiösen Arthritis

Biologic predictors of clinical improvement in rituximab-treated refractory myositis

Administration costs of intravenous biologic drugs for rheumatoid arthritis

Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study

Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis

Was führt zur Antibiotika-refraktären Lyme-Arthritis bei Kindern?

Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy

Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America

Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?

Persistent Lyme Empiric Antibiotic Study Europe (PLEASE) - design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis

Klinische und serologische Verlaufskontrollen bei 149 Patienten mit Lyme-Borreliose (Lyme-Arthritis, Erythema migrans, Acrodermatitis chronica atrophicans)

Related objects

Reset password